CA Stock MarketDetailed Quotes

CRDL Cardiol Therapeutics Inc

Watchlist
  • 2.520
  • -0.020-0.79%
15min DelayMarket Closed Nov 18 16:00 ET
200.55MMarket Cap-4666P/E (TTM)

Cardiol Therapeutics Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-127.53%-7.77M
10.81%-4.78M
30.40%-6.92M
7.49%-25.18M
48.47%-6.46M
-101.63%-3.41M
-108.62%-5.35M
4.49%-9.95M
-15.64%-27.22M
-213.93%-12.55M
Net income from continuing operations
-114.64%-12.73M
11.79%-6.59M
-29.49%-9.18M
9.06%-28.13M
-1.62%-7.64M
25.61%-5.93M
-15.14%-7.47M
20.83%-7.09M
2.24%-30.93M
-20.10%-7.52M
Operating gains losses
-273.37%-997.43K
-8,212.79%-840.73K
1,814.59%1.32M
87.91%-943.76K
78.36%-1.45M
-61.16%575.32K
-98.90%10.36K
97.82%-76.84K
-61.88%-7.81M
---6.71M
Depreciation and amortization
209.88%201.09K
5.83%61.91K
5.87%61.62K
12.94%248.36K
15.04%66.76K
19.12%64.89K
8.77%58.5K
8.55%58.21K
-0.23%219.91K
4.40%58.03K
Remuneration paid in stock
310.69%8.42M
170.95%1.81M
111.35%902.1K
-17.08%4.16M
6.83%1.01M
-42.73%2.05M
214.46%666.4K
-59.98%426.82K
-41.01%5.01M
-79.34%947.96K
Other non cashItems
6.55%6.33K
362.65%6.37K
-63.28%6.64K
-93.94%32.38K
100.55%6.98K
-97.28%5.94K
-99.81%1.38K
-97.91%18.08K
-87.05%534.43K
-220.09%-1.26M
Change In working capital
-1,374.47%-2.67M
-43.36%782.04K
99.06%-31.03K
-109.50%-545.88K
-20.63%1.54M
-119.22%-181.28K
-50.57%1.38M
-4,564.67%-3.28M
7,411.68%5.75M
39.71%1.94M
-Change in receivables
-256.92%-24.28K
-27.56%74.68K
-151.69%-37.23K
374.15%200.33K
134.57%9.72K
131.94%15.47K
25.15%103.09K
191.33%72.03K
60.97%-73.07K
-29.27%-28.12K
-Change in inventory
----
----
----
--0
----
----
----
----
--0
----
-Change in prepaid assets
321.98%487.86K
-84.50%129.09K
-8.14%-805.5K
-59.41%546.47K
137.56%678.38K
-122.24%-219.77K
29.43%832.72K
-30.52%-744.86K
162.70%1.35M
130.65%285.56K
-Change in payables and accrued expense
-13,728.33%-3.14M
29.97%578.26K
131.09%811.71K
-128.89%-1.29M
-49.42%850.28K
575.52%23.02K
-78.48%444.93K
-461.06%-2.61M
86.99%4.47M
-28.19%1.68M
Cash from discontinued investing activities
Operating cash flow
-127.53%-7.77M
10.81%-4.78M
30.40%-6.92M
7.49%-25.18M
48.47%-6.46M
-101.63%-3.41M
-108.62%-5.35M
4.49%-9.95M
-15.64%-27.22M
-213.93%-12.55M
Investing cash flow
Cash flow from continuing investing activities
-41.13%-7.87K
2.34%-3.8K
92.16%-3.46K
13.92%-64.31K
77.62%-10.71K
39.95%-5.58K
-82.85%-3.89K
-185.44%-44.14K
-478.42%-74.71K
-47.83K
Net PPE purchase and sale
-41.13%-7.87K
2.34%-3.8K
92.16%-3.46K
13.92%-64.31K
77.62%-10.71K
39.95%-5.58K
-82.85%-3.89K
-185.44%-44.14K
-478.42%-74.71K
---47.83K
Cash from discontinued investing activities
Investing cash flow
-41.13%-7.87K
2.34%-3.8K
92.16%-3.46K
13.92%-64.31K
77.62%-10.71K
39.95%-5.58K
-82.85%-3.89K
-185.44%-44.14K
-478.42%-74.71K
---47.83K
Financing cash flow
Cash flow from continuing financing activities
66.66%-4.62K
664.03%78.08K
651.52%76.35K
-2.67%-55.38K
0.00%-13.84K
0.00%-13.84K
-4.35%-13.84K
-6.66%-13.84K
-100.06%-53.93K
-100.02%-13.84K
Net issuance payments of debt
66.66%-4.62K
33.34%-9.23K
0.00%-13.84K
-2.67%-55.38K
0.00%-13.84K
0.00%-13.84K
-4.35%-13.84K
-6.66%-13.84K
-3.89%-53.93K
-6.66%-13.84K
Net common stock issuance
----
----
----
--0
----
----
----
----
--0
----
Proceeds from stock option exercised by employees
--0
--87.31K
--90.2K
--0
--0
--0
--0
--0
--0
----
Cash from discontinued financing activities
Financing cash flow
66.66%-4.62K
664.03%78.08K
651.52%76.35K
-2.67%-55.38K
0.00%-13.84K
0.00%-13.84K
-4.35%-13.84K
-6.66%-13.84K
-100.06%-53.93K
-100.02%-13.84K
Net cash flow
Beginning cash position
-46.55%24.02M
-42.24%28.57M
-41.26%34.93M
-29.12%59.47M
-38.14%40.54M
-36.21%44.94M
-33.91%49.47M
-29.12%59.47M
498.20%83.9M
128.72%65.53M
Current changes in cash
-126.61%-7.78M
12.48%-4.7M
31.53%-6.85M
7.49%-25.3M
48.53%-6.49M
-100.05%-3.43M
-108.06%-5.37M
4.20%-10M
-139.13%-27.35M
-122.82%-12.61M
Effect of exchange rate changes
63.37%-354.66K
-82.32%149.68K
17,693.37%491.1K
-73.90%762.04K
-86.54%880.95K
69.79%-968.2K
146.82%846.53K
-99.80%2.76K
26,335.83%2.92M
--6.54M
End cash Position
-60.82%15.89M
-46.55%24.02M
-42.24%28.57M
-41.26%34.93M
-41.26%34.93M
-38.14%40.54M
-36.21%44.94M
-33.91%49.47M
-29.12%59.47M
-29.12%59.47M
Free cash from
-127.39%-7.78M
10.80%-4.78M
30.67%-6.93M
7.51%-25.24M
48.58%-6.48M
-100.86%-3.42M
-108.59%-5.36M
4.21%-9.99M
-15.89%-27.3M
-215.13%-12.59M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -127.53%-7.77M10.81%-4.78M30.40%-6.92M7.49%-25.18M48.47%-6.46M-101.63%-3.41M-108.62%-5.35M4.49%-9.95M-15.64%-27.22M-213.93%-12.55M
Net income from continuing operations -114.64%-12.73M11.79%-6.59M-29.49%-9.18M9.06%-28.13M-1.62%-7.64M25.61%-5.93M-15.14%-7.47M20.83%-7.09M2.24%-30.93M-20.10%-7.52M
Operating gains losses -273.37%-997.43K-8,212.79%-840.73K1,814.59%1.32M87.91%-943.76K78.36%-1.45M-61.16%575.32K-98.90%10.36K97.82%-76.84K-61.88%-7.81M---6.71M
Depreciation and amortization 209.88%201.09K5.83%61.91K5.87%61.62K12.94%248.36K15.04%66.76K19.12%64.89K8.77%58.5K8.55%58.21K-0.23%219.91K4.40%58.03K
Remuneration paid in stock 310.69%8.42M170.95%1.81M111.35%902.1K-17.08%4.16M6.83%1.01M-42.73%2.05M214.46%666.4K-59.98%426.82K-41.01%5.01M-79.34%947.96K
Other non cashItems 6.55%6.33K362.65%6.37K-63.28%6.64K-93.94%32.38K100.55%6.98K-97.28%5.94K-99.81%1.38K-97.91%18.08K-87.05%534.43K-220.09%-1.26M
Change In working capital -1,374.47%-2.67M-43.36%782.04K99.06%-31.03K-109.50%-545.88K-20.63%1.54M-119.22%-181.28K-50.57%1.38M-4,564.67%-3.28M7,411.68%5.75M39.71%1.94M
-Change in receivables -256.92%-24.28K-27.56%74.68K-151.69%-37.23K374.15%200.33K134.57%9.72K131.94%15.47K25.15%103.09K191.33%72.03K60.97%-73.07K-29.27%-28.12K
-Change in inventory --------------0------------------0----
-Change in prepaid assets 321.98%487.86K-84.50%129.09K-8.14%-805.5K-59.41%546.47K137.56%678.38K-122.24%-219.77K29.43%832.72K-30.52%-744.86K162.70%1.35M130.65%285.56K
-Change in payables and accrued expense -13,728.33%-3.14M29.97%578.26K131.09%811.71K-128.89%-1.29M-49.42%850.28K575.52%23.02K-78.48%444.93K-461.06%-2.61M86.99%4.47M-28.19%1.68M
Cash from discontinued investing activities
Operating cash flow -127.53%-7.77M10.81%-4.78M30.40%-6.92M7.49%-25.18M48.47%-6.46M-101.63%-3.41M-108.62%-5.35M4.49%-9.95M-15.64%-27.22M-213.93%-12.55M
Investing cash flow
Cash flow from continuing investing activities -41.13%-7.87K2.34%-3.8K92.16%-3.46K13.92%-64.31K77.62%-10.71K39.95%-5.58K-82.85%-3.89K-185.44%-44.14K-478.42%-74.71K-47.83K
Net PPE purchase and sale -41.13%-7.87K2.34%-3.8K92.16%-3.46K13.92%-64.31K77.62%-10.71K39.95%-5.58K-82.85%-3.89K-185.44%-44.14K-478.42%-74.71K---47.83K
Cash from discontinued investing activities
Investing cash flow -41.13%-7.87K2.34%-3.8K92.16%-3.46K13.92%-64.31K77.62%-10.71K39.95%-5.58K-82.85%-3.89K-185.44%-44.14K-478.42%-74.71K---47.83K
Financing cash flow
Cash flow from continuing financing activities 66.66%-4.62K664.03%78.08K651.52%76.35K-2.67%-55.38K0.00%-13.84K0.00%-13.84K-4.35%-13.84K-6.66%-13.84K-100.06%-53.93K-100.02%-13.84K
Net issuance payments of debt 66.66%-4.62K33.34%-9.23K0.00%-13.84K-2.67%-55.38K0.00%-13.84K0.00%-13.84K-4.35%-13.84K-6.66%-13.84K-3.89%-53.93K-6.66%-13.84K
Net common stock issuance --------------0------------------0----
Proceeds from stock option exercised by employees --0--87.31K--90.2K--0--0--0--0--0--0----
Cash from discontinued financing activities
Financing cash flow 66.66%-4.62K664.03%78.08K651.52%76.35K-2.67%-55.38K0.00%-13.84K0.00%-13.84K-4.35%-13.84K-6.66%-13.84K-100.06%-53.93K-100.02%-13.84K
Net cash flow
Beginning cash position -46.55%24.02M-42.24%28.57M-41.26%34.93M-29.12%59.47M-38.14%40.54M-36.21%44.94M-33.91%49.47M-29.12%59.47M498.20%83.9M128.72%65.53M
Current changes in cash -126.61%-7.78M12.48%-4.7M31.53%-6.85M7.49%-25.3M48.53%-6.49M-100.05%-3.43M-108.06%-5.37M4.20%-10M-139.13%-27.35M-122.82%-12.61M
Effect of exchange rate changes 63.37%-354.66K-82.32%149.68K17,693.37%491.1K-73.90%762.04K-86.54%880.95K69.79%-968.2K146.82%846.53K-99.80%2.76K26,335.83%2.92M--6.54M
End cash Position -60.82%15.89M-46.55%24.02M-42.24%28.57M-41.26%34.93M-41.26%34.93M-38.14%40.54M-36.21%44.94M-33.91%49.47M-29.12%59.47M-29.12%59.47M
Free cash from -127.39%-7.78M10.80%-4.78M30.67%-6.93M7.51%-25.24M48.58%-6.48M-100.86%-3.42M-108.59%-5.36M4.21%-9.99M-15.89%-27.3M-215.13%-12.59M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data